---
document_datetime: 2024-12-12 16:59:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/relistor-epar-all-authorised-presentations_en.pdf
document_name: relistor-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7054856
conversion_datetime: 2025-12-26 10:06:58.626816
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/08/463/001   | Relistor   | 12 mg/0.6 ml   | Solution for injection   | Subcutaneous use   | vial (glass)               | 0.6 ml (20 mg/ml)   | 1 vial                                                                |
|-------------------|------------|----------------|--------------------------|--------------------|----------------------------|---------------------|-----------------------------------------------------------------------|
| EU/1/08/463/002   | Relistor   | 12 mg/0.6 ml   | Solution for injection   | Subcutaneous use   | vial (glass)               | 0.6 ml (20 mg/ml)   | 2 vials + 2 sterile syringes + 4                                      |
| EU/1/08/463/003   | Relistor   | 12 mg/0.6 ml   | Solution for injection   | Subcutaneous use   | vial (glass)               | 0.6 ml (20 mg/ml)   | alcohol swabs 7 vials + 7 sterile syringes + 14 alcohol swabs         |
| EU/1/08/463/004   | Relistor   | 8 mg           | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.4 ml (20 mg/ml)   | 4 pre-filled syringes                                                 |
| EU/1/08/463/005   | Relistor   | 8 mg           | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.4 ml (20 mg/ml)   | 7 pre-filled syringes                                                 |
| EU/1/08/463/006   | Relistor   | 8 mg           | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.4 ml (20 mg/ml)   | 8 pre-filled syringes                                                 |
| EU/1/08/463/007   | Relistor   | 8 mg           | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.4 ml (20 mg/ml)   | 10 pre-filled syringes                                                |
| EU/1/08/463/008   | Relistor   | 12 mg          | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.6 ml (20 mg/ml)   | 4 pre-filled syringes                                                 |
| EU/1/08/463/009   | Relistor   | 12 mg          | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.6 ml (20 mg/ml)   | 7 pre-filled syringes                                                 |
| EU/1/08/463/010   | Relistor   | 12 mg          | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.6 ml (20 mg/ml)   | 8 pre-filled syringes                                                 |
| EU/1/08/463/011   | Relistor   | 12 mg          | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) | 0.6 ml (20 mg/ml)   | 10 pre-filled syringes                                                |
| EU/1/08/463/012   | Relistor   | 12 mg/0.6 ml   | Solution for injection   | Subcutaneous use   | vial (glass)               | 0.6 ml (20 mg/ml)   | 2 vials + 2 sterile syringes with safeguard needle + 4 alcohol swabs  |
| EU/1/08/463/013   | Relistor   | 12 mg/0.6 ml   | Solution for injection   | Subcutaneous use   | vial (glass)               | 0.6 ml (20 mg/ml)   | 7 vials + 7 sterile syringes with safeguard needle + 14 alcohol swabs |